NextCure Inc (NASDAQ:NXTC) — Market Cap & Net Worth
Market Cap & Net Worth: NextCure Inc (NXTC)
NextCure Inc (NASDAQ:NXTC) has a market capitalization of $32.81 Million ($32.81 Million) as of May 4, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #23415 globally and #4861 in its home market, demonstrating a -24.52% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying NextCure Inc's stock price $9.36 by its total outstanding shares 3505621 (3.51 Million). Analyse NXTC cash flow conversion to see how efficiently the company converts income to cash.
NextCure Inc Market Cap History: 2019 to 2026
NextCure Inc's market capitalization history from 2019 to 2026. Data shows change from $197.47 Million to $32.81 Million (-10.24% CAGR).
Index Memberships
NextCure Inc is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.41 Trillion | 0.00% | #674 of 976 |
|
NASDAQ Composite
IXIC
|
$38.77 Trillion | 0.00% | #2236 of 3165 |
Weight: NextCure Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
NextCure Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how NextCure Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
1.71x
NextCure Inc's market cap is 1.71 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2019 | $197.47 Million | $6.35 Million | -$33.74 Million | 31.11x | N/A |
| 2020 | $38.21 Million | $22.38 Million | -$33.19 Million | 1.71x | N/A |
Competitor Companies of NXTC by Market Capitalization
Companies near NextCure Inc in the global market cap rankings as of May 4, 2026.
Key companies related to NextCure Inc by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #223 globally with a market cap of $107.56 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #367 globally with a market cap of $72.88 Billion USD.
- UCB SA (BR:UCB): Ranked #517 globally with a market cap of $51.45 Billion USD ( €44.01 Billion EUR).
- argenx NV ADR (NASDAQ:ARGX): Ranked #568 globally with a market cap of $45.97 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #223 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $107.56 Billion | $423.92 |
| #367 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $72.88 Billion | $701.42 |
| #517 | UCB SA | BR:UCB | $51.45 Billion | €231.20 |
| #568 | argenx NV ADR | NASDAQ:ARGX | $45.97 Billion | $787.95 |
NextCure Inc Historical Marketcap From 2019 to 2026
Between 2019 and today, NextCure Inc's market cap moved from $197.47 Million to $ 32.81 Million, with a yearly change of -10.24%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $32.81 Million | -34.04% |
| 2025 | $49.74 Million | +1740.47% |
| 2024 | $2.70 Million | -32.37% |
| 2023 | $4.00 Million | -19.15% |
| 2022 | $4.94 Million | -76.50% |
| 2021 | $21.03 Million | -44.95% |
| 2020 | $38.21 Million | -80.65% |
| 2019 | $197.47 Million | -- |
End of Day Market Cap According to Different Sources
On May 4th, 2026 the market cap of NextCure Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $32.81 Million USD |
| MoneyControl | $32.81 Million USD |
| MarketWatch | $32.81 Million USD |
| marketcap.company | $32.81 Million USD |
| Reuters | $32.81 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About NextCure Inc
NextCure, Inc., a clinical-stage biopharmaceutical company, engages in advancing medicines to treat cancer. The company's product candidate is the LNCB74, a B7-H4 targeted ADC to kill tumors. It also develops NC410, a fusion protein of LAIR-2, that is designed to block immune suppression mediated by LAIR-1; NC525, a novel LAIR-1 antibody that targets acute myeloid leukemia, blast cells, and leuke… Read more